Ad Astra Diagnostics, Inc. is a biotechnology and manufacturing startup founded in 2022 and headquartered in the United States. The company is focused on the development of rapid diagnostic and data systems, with a mission to revolutionize the way healthcare diagnostics are performed. Their slogan, "Developer of rapid diagnostic and data systems.", encapsulates their core objective. The startup recently received a non-equity assistance investment on 13 September 2023 from Springboard Enterprises, indicating investor confidence in the company's potential. Ad Astra Diagnostics, Inc. stands at the intersection of biotechnology and data innovation, aiming to carve a significant niche in the healthcare industry with its pioneering solutions.